肿瘤疗效评价标准中英文.docVIP

  • 4
  • 0
  • 约1.37万字
  • 约 7页
  • 2019-08-22 发布于江西
  • 举报
Response Evaluation Criteria in Solid Tumors (RECIST) Quick Reference: Eligibility ·??Only patients with measurable disease at baseline should be included in protocols where objective tumor response is the primary endpoint. Measurable disease - the presence of at least one measurable lesion. If the measurable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology. Measurable lesions - lesions that can be accurately measured in at least one dimension with longest diameter 320 mm using conventional techniques or 310 mm with spiral CT scan.

文档评论(0)

1亿VIP精品文档

相关文档